Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7449 p476
28 April 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Study highlights training needs for supervised methadone providers

Report: Supervised methadone in Staffordshire and Shropshire

“Supervised methadone in Staffordshire and Shropshire” was released last week

Training is essential for all staff involved with supervised methadone schemes and should be multidisciplinary, according to a recent study.

The study, undertaken by researchers at Keele University and published last week by the National Treatment Agency for Substance Misuse, looked at supervised methadone schemes in four drug action team areas across Staffordshire and Shropshire.

The researchers reveal that 60 per cent of pharmacists identified a need for training on drug misuse and blood-borne diseases.

Catriona Matheson, senior research fellow, department of general practice and primary care, University of Aberdeen, was an external consultant for the work. She commented: “Training needs in managing aggression, as well as the basics of understanding addiction and the use of methadone, were specifically noted. The profession should consider how to facilitate this training need at a higher level.” Dr Matheson pointed out that there is considerable scope for joint training of pharmacists and other health professionals, a key suggestion of the report.

According to the study, around half of GPs said that they required further training. Dr Matheson suggested that pharmacists should understand this and be supportive if possible: “This would help integrate pharmacists into the multidisciplinary model of care that is clearly needed given that the report noted the limited input of pharmacists to the wider team.”

The study report also says that only one of the four drug action teams had guidelines that made recommendations on pharmacist training. “Analysis of the questionnaire responses and the semi-structured interviews reveal a gap between the contract specifications and the reality of implementation,” the author says.

Individual pharmacists have considerable scope to give out more health promotion information, said Dr Matheson. Of the pharmacists surveyed, more than 60 per cent did not provide leaflets, less than half never gave face-to-face advice on managing drug misuse and nearly three quarters gave no advice on HIV prevention. Dr Matheson explained: “I sometimes think pharmacists consider drug users to know what they are doing and all about what they are taking — this is not the case and pharmacists should use their own knowledge more confidently.”

Back to Top


©The Pharmaceutical Journal